Poulvac MG
Poulvac MG
Authorised
- Mycoplasma gallisepticum, strain R-980, Inactivated
Product identification
Medicine name:
Poulvac MG
Active substance:
- Mycoplasma gallisepticum, strain R-980, Inactivated
Target species:
-
Chicken
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Mycoplasma gallisepticum, strain R-980, Inactivated70.00/Percentage protective dose0.50millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Chicken
-
Meat and offal6week
-
-
-
Subcutaneous use
-
Chicken
-
Meat and offal6week
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 80a/88
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 15/08/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 15/08/2022
How useful was this page?:
